AcelRx Pharmaceuticals
ACRX
$0.86
Share price
7.50%
Change (1 day)
40.98%
Change (1 year)
Categories
AcelRx Pharmaceuticals (ACRX) - Total assets
Total assets on the balance sheet as of December 2023 : $20.39 M
According to AcelRx Pharmaceuticals 's latest financial reports the company's total assets are $20.39 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
AcelRx Pharmaceuticals - Total assets on balance sheet (from 2009 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $47.48 M | -39.04% |
| 2021-12-31 | $77.89 M | 17.49% |
| 2020-12-31 | $66.29 M | -27.43% |
| 2019-12-31 | $91.35 M | -24.21% |
| 2018-12-31 | $0.12 B | 59.54% |
| 2017-12-31 | $75.55 M | -24.44% |
| 2016-12-31 | $99.99 M | -21.75% |
| 2015-12-31 | $0.12 B | 47.82% |
| 2014-12-31 | $86.44 M | -21.43% |
| 2013-12-31 | $0.11 B | 70.54% |
| 2012-12-31 | $64.52 M | 58% |
| 2011-12-31 | $40.83 M | 497.88% |
| 2010-12-31 | $6.83 M | -52.87% |
| 2009-12-31 | $14.49 M | -36.1% |
| 2008-12-31 | $22.67 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.12 B | 517.03% | 🇺🇸 USA |